(Q42548566)
English
Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized con
scientific article published on 3 February 2016
Statements
Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial (English)
Denise A Yardley
Adam Brufsky
Robert E Coleman
Stefan Glück
Jean-Mark A Nabholtz
Robert M Beck
Amy Ko
Markus F Renschler
Debora Barton
3 February 2016
Identifiers
1 reference